Axon Enterprise Inc Forecast, price target & analysts
Axon Enterprise Inc Target price 2025 - Analyst rating & recommendation
Axon Enterprise Inc Classifications & Recommendation:
Axon Enterprise Inc Price Target
| Target Price | $726.92 |
| Price | $728.39 |
| Deviation | 0.20% |
| Number of Estimates | 13 |
| 13 Analysts have issued a price target Axon Enterprise Inc 2026 . The average Axon Enterprise Inc target price is $726.92. This is 0.20% lower than the current stock price. The highest price target is $830.00 13.95% , the lowest is $610.00 16.25% . | |
| A rating was issued by 18 analysts: 15 Analysts recommend Axon Enterprise Inc to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Axon Enterprise Inc stock has an average upside potential 2026 of 0.20% . Most analysts recommend the Axon Enterprise Inc stock at Purchase. |
Sales and Margin forecast 2025, 2026 & 2027
13 Analysts have issued a sales forecast Axon Enterprise Inc 2025 . The average Axon Enterprise Inc sales estimate is $2.7b . This is 19.20% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $2.7b 20.56% , the lowest is $2.6b 17.99% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $2.1b | 33.44% |
|---|---|---|
| 2025 | $2.7b | 27.48% |
| 2026 | $3.3b | 22.97% |
| 2027 | $3.9b | 19.02% |
13 Analysts have issued an Axon Enterprise Inc EBITDA forecast 2025. The average Axon Enterprise Inc EBITDA estimate is $671m . This is 637.74% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $691m 660.29% , the lowest is $663m 628.70% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $112m | 37.53% |
|---|---|---|
| 2025 | $671m | 500.65% |
| 2026 | $857m | 27.80% |
| 2027 | $1.2b | 35.95% |
EBITDA Margin
| 2024 | 5.36% | 53.19% |
|---|---|---|
| 2025 | 25.27% | 371.26% |
| 2026 | 26.26% | 3.92% |
| 2027 | 29.99% | 14.20% |
8 Axon Enterprise Inc Analysts have issued a net profit forecast 2025. The average Axon Enterprise Inc net profit estimate is $95.1m . This is 70.43% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $170m 46.97% , the lowest is $17.1m 94.67% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $374m | 106.01% |
|---|---|---|
| 2025 | $95.1m | 74.56% |
| 2026 | $166m | 74.63% |
Net Margin
| 2024 | 17.94% | 54.39% |
|---|---|---|
| 2025 | 3.58% | 80.05% |
| 2026 | 5.09% | 42.18% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
8 Analysts have issued a Axon Enterprise Inc forecast for earnings per share. The average Axon Enterprise Inc EPS is $1.22 . This is 70.46% lower than earnings per share in the financial year 2024. The highest EPS forecast is $2.19 46.97% , the lowest is $0.22 94.67% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $4.80 | 106.01% |
|---|---|---|
| 2025 | $1.22 | 74.58% |
| 2026 | $2.13 | 74.59% |
P/E ratio
| Current | 176.31 | 98.91% |
|---|---|---|
| 2025 | 596.43 | 238.28% |
| 2026 | 341.57 | 42.73% |
Based on analysts' sales estimates for 2025, the Axon Enterprise Inc stock is valued at an EV/Sales of 21.23 and an P/S ratio of 21.36 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 25.31 | 88.74% |
|---|---|---|
| 2025 | 21.23 | 16.10% |
| 2026 | 17.27 | 18.68% |
| 2027 | 14.51 | 15.98% |
P/S ratio
| Current | 25.46 | 86.92% |
|---|---|---|
| 2025 | 21.36 | 16.11% |
| 2026 | 17.37 | 18.68% |
| 2027 | 14.59 | 15.98% |
Axon Enterprise Inc...
Current Axon Enterprise Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Goldman Sachs |
Buy
➜
Buy
|
Unchanged | May 14 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | May 09 2025 |
| Needham |
Buy
➜
Buy
|
Unchanged | May 08 2025 |
| Needham |
Buy
➜
Buy
|
Unchanged | Apr 23 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Feb 27 2025 |
| Needham |
Buy
➜
Buy
|
Unchanged | Feb 26 2025 |
| Citizens Capital Markets |
Market Outperform
➜
Market Outperform
|
Unchanged | Feb 26 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Goldman Sachs:
Buy
➜
Buy
|
May 14 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
May 09 2025 |
|
Unchanged
Needham:
Buy
➜
Buy
|
May 08 2025 |
|
Unchanged
Needham:
Buy
➜
Buy
|
Apr 23 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Feb 27 2025 |
|
Unchanged
Needham:
Buy
➜
Buy
|
Feb 26 2025 |
|
Unchanged
Citizens Capital Markets:
Market Outperform
➜
Market Outperform
|
Feb 26 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
